Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option
★★★★★ monitor_heart Health Score: 72/100 · GoodBaroda BNP Paribas Mutual Fund · Equity · Large & Mid Cap Fund
₹27.03
AUM: ₹1,752 Cr
NAV updated about 1 month ago
Plan
Regular
Option
Growth
Risk
High
Expense Ratio
1.21%
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days.
Fund Manager
Ashwani Kumar
Inception
Sep 2020
Benchmark
BSE 250 Large MidCap Total Return Index
Sharpe Ratio
-0.45
Std Dev (1Y)
14.99%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+1.48%
3m
+3.37%
6m
-2.99%
1y
-0.04%
3y
+16.19%
5y
+15.39%
10y
—
since inception
+18.43%
rate_review TopFund's Take on Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option
Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option holds up reasonably well within the Large & Mid Cap Fund category, currently carrying a 3-star rating. It has delivered steady, if unspectacular, returns over a full market cycle. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 72/100.
Cost: At 1.21%, the expense ratio is roughly in line with the Large & Mid Cap Fund category average of 1.15% — cost isn't a standout factor either way for this fund.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.45 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 14.99% is fairly typical for actively managed equity funds.
Who should invest: This fund is best suited to investors with a 5+ year horizon comfortable with meaningfully higher volatility than large cap funds. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
donut_small Sector Allocation
pie_chart Asset Allocation
info Fund Snapshot
Similar Funds
ICICI Prudential Large & Mid Cap Fund - Direct Plan - Growth
ICICI Prudential Mutual Fund
Nippon India Vision Large & Mid Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Whiteoak Capital Large & Mid Cap Fund Direct Plan Growth
WhiteOak Capital Mutual Fund
Franklin India Large & Mid Cap Fund - Direct - Growth
Franklin Templeton Mutual Fund
CANARA ROBECO LARGE AND MID CAP FUND - DIRECT PLAN - GROWTH OPTION
Canara Robeco Mutual Fund
tips_and_updates Tools & Guides for This Fund
Frequently Asked Questions about Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option
The current NAV (Net Asset Value) of Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option is ₹27.03. NAV is updated every business day after market close by AMFI.
1Y: -0.04% · 3Y CAGR: 16.19% · 5Y CAGR: 15.39%
The expense ratio is 1.21% per annum — the annual fee deducted from your investment to cover fund management costs.
Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option is managed by Ashwani Kumar at Baroda BNP Paribas Mutual Fund.
Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option is a High risk fund. Suitable for investors with a 3+ year horizon.
Yes, Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option is an equity fund, making it suitable for SIP investments. Regular monthly SIPs help average out market volatility through rupee-cost averaging.
The Assets Under Management (AUM) of Baroda BNP Paribas Large and Mid Cap Fund-Regular Plan-Growth Option is ₹1,752 crore as of the latest data.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.